NAICS Code 621511-23 - Fibromyalgia Diagnosis & Treatment

Marketing Level - NAICS 8-Digit

Business Lists and Databases Available for Marketing and Research

Total Verified Companies: 2
Contact Emails: Inquire
Company Websites: 2
Phone Numbers: 2
Business Addresses: 2
Companies with Email: 1
Reach new customers, connect with decision makers, and grow your business.
Pricing from $0.05 to $0.25 per lead

Business List Pricing Tiers

Quantity of Records Price Per Record Estimated Total (Max in Tier)
0 - 1,000 $0.25 Up to $250
1,001 - 2,500 $0.20 Up to $500
2,501 - 10,000 $0.15 Up to $1,500
10,001 - 25,000 $0.12 Up to $3,000
25,001 - 50,000 $0.09 Up to $4,500
50,000+ Contact Us for a Custom Quote

What's Included in Every Standard Data Package

  • Company Name
  • Contact Name (where available)
  • Job Title (where available)
  • Full Business & Mailing Address
  • Business Phone Number
  • Industry Codes (Primary and Secondary SIC & NAICS Codes)
  • Sales Volume
  • Employee Count
  • Website (where available)
  • Years in Business
  • Location Type (HQ, Branch, Subsidiary)
  • Modeled Credit Rating
  • Public / Private Status
  • Latitude / Longitude
  • ...and more (Inquire)

Boost Your Data with Verified Email Leads

Enhance your list or opt for a complete 100% verified email list – all for just $0.10 per email!

Ideal for: Direct Mailing Email Campaigns Calling Market ResearchFree Sample & Report, Custom Lists, and Expert Support — All Included
Looking for more companies? See NAICS 621511 - Medical Laboratories - 11,173 companies, 48,597 emails.

NAICS Code 621511-23 Description (8-Digit)

Fibromyalgia Diagnosis & Treatment is a specialized subdivision of the Medical Laboratories industry that focuses on the diagnosis and treatment of fibromyalgia, a chronic disorder characterized by widespread musculoskeletal pain, fatigue, and tenderness in localized areas. This industry involves the use of various diagnostic tools and treatment methods to help patients manage their symptoms and improve their quality of life.

Parent Code - Official US Census

Official 6‑digit NAICS codes serve as the parent classification used for government registrations and documentation. The marketing-level 8‑digit codes act as child extensions of these official classifications, providing refined segmentation for more precise targeting and detailed niche insights. Related industries are listed under the parent code, offering a broader context of the industry environment. For further details on the official classification for this industry, please visit the U.S. Census Bureau NAICS Code 621511 page

Tools

Tools commonly used in the Fibromyalgia Diagnosis & Treatment industry for day-to-day tasks and operations.

  • Tender point exam
  • Blood tests
  • Magnetic resonance imaging (MRI)
  • X-rays
  • Sleep studies
  • Physical therapy equipment
  • Pain scales
  • Cognitive behavioral therapy (CBT) materials
  • Medications for pain management
  • Acupuncture needles

Industry Examples of Fibromyalgia Diagnosis & Treatment

Common products and services typical of NAICS Code 621511-23, illustrating the main business activities and contributions to the market.

  • Fibromyalgia clinics
  • Pain management centers
  • Rheumatology practices
  • Physical therapy practices
  • Integrative medicine clinics
  • Neurology practices
  • Sleep disorder clinics
  • Rehabilitation centers
  • Wellness centers
  • Alternative medicine practices

History

A concise historical narrative of NAICS Code 621511-23 covering global milestones and recent developments within the United States.

  • The history of Fibromyalgia Diagnosis & Treatment industry dates back to the early 1800s when the first case of fibromyalgia was reported. However, it was not until the 1970s that the condition was recognized as a distinct medical condition. In 1990, the American College of Rheumatology established diagnostic criteria for fibromyalgia, which helped to standardize the diagnosis of the condition. Since then, there have been several notable advancements in the industry, including the development of new medications and therapies to manage the symptoms of fibromyalgia. In the United States, the history of the Fibromyalgia Diagnosis & Treatment industry is closely tied to the history of chronic pain management. In the 1990s, there was a significant increase in the number of prescriptions for opioid painkillers, which led to a rise in opioid addiction and overdose deaths. As a result, there has been a growing interest in non-opioid pain management strategies, including those used to treat fibromyalgia. In recent years, there has been a greater focus on developing personalized treatment plans for patients with fibromyalgia, which take into account their individual symptoms and medical history.